Conference abstract · 2018
Conference abstractPublished 27 Oct 2016
Structure and mechanism based drug design, discovery and development
University of Kentucky, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In this talk, I will first give a brief overview of drug discovery and development through state-of-the-art computational design and discuss the general trend of computational drug design and discovery through specific examples of our recent efforts in drug design, discovery and development (from computational design to clinical development). The presentation will show how the state-of-the-art computational modeling and design can effectively be integrated with wet experimental tests (in vitro and in vivo) for drug discovery and development. Appropriately integrated with wet experimental studies, state-of-the-art computational design is of great value not only for small molecule drug discovery, but also for discovery and development of novel therapeutic proteins engineered from naturally occurring proteins. Integrated computational-experimental drug design and discovery efforts have led to exciting discovery of promising drug candidates, including two Investigational New Drugs (INDs) that are in clinical development; one has received the breakthrough therapy designation by the FDA.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Integrated product development: Structure based drug design integration of structurebased drug design in drug discovery
Conference abstract · 11 Aug 2015
Current progress in structure-based rational drug design marks a new mindset in drug discovery
Conference abstract · 18 Sep 2017
Structure Based Drug Discovery on Membrane Protein Targets: New developments and advancements
Conference abstract · 15 Oct 2013
SARS antiviral therapeutic development through structure and ligand-based drug design
More from this journal
The newest in Drug Designing: Open Access.
Research article · 19 Aug 2025
Spectroscopic, Quantum Chemical, Molecular Docking Studies on Cellulose Acetate: Polyvinylidene Fluoride Blend Polymer Membrane for Wound Healing
Research article · 18 Apr 2025
Molecular Docking Studies on Polyphenols of Moringa oleifera for its Enhanced Production of Heamoglobin and Impact of its Extracts on Drosophila melanogaster
Opinion · 4 Mar 2025
Structure-Based Drug Design: Advances in Targeting Oncogenic Kinases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDrug Designing: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chang-Guo Zhan”

